Theratechnologies Inc. (TH.TO)
CAD 2.18
(0.46%)
CAD 2.18
(0.46%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 77.76 Million USD | -16.61% |
| 2022 | 93.26 Million USD | -21.77% |
| 2021 | 119.21 Million USD | 19.04% |
| 2020 | 100.14 Million USD | -14.81% |
| 2019 | 117.55 Million USD | 5.66% |
| 2018 | 111.25 Million USD | 87.65% |
| 2017 | 59.28 Million USD | 50.36% |
| 2016 | 39.42 Million USD | 5.27% |
| 2015 | 37.45 Million USD | 31.39% |
| 2014 | 28.5 Million USD | 21.82% |
| 2013 | 23.4 Million USD | -36.02% |
| 2012 | 36.57 Million USD | -28.57% |
| 2011 | 51.2 Million USD | -27.14% |
| 2010 | 70.27 Million USD | 6.98% |
| 2009 | 65.69 Million USD | 50.69% |
| 2008 | 43.59 Million USD | -41.52% |
| 2007 | 74.55 Million USD | 66.97% |
| 2006 | 44.65 Million USD | -2.79% |
| 2005 | 45.93 Million USD | -19.74% |
| 2004 | 57.22 Million USD | -21.47% |
| 2003 | 72.87 Million USD | -18.83% |
| 2002 | 89.78 Million USD | -0.66% |
| 2001 | 90.37 Million USD | 64.34% |
| 2000 | 54.99 Million USD | 198.81% |
| 1999 | 18.4 Million USD | 48.0% |
| 1998 | 12.43 Million USD | 46.24% |
| 1997 | 8.5 Million USD | -47.68% |
| 1996 | 16.25 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 69.71 Million USD | -0.71% |
| 2024 Q1 | 72.09 Million USD | -7.3% |
| 2024 Q2 | 70.21 Million USD | -2.6% |
| 2023 Q1 | 79.24 Million USD | -15.03% |
| 2023 FY | 77.76 Million USD | -16.61% |
| 2023 Q4 | 77.76 Million USD | 37.19% |
| 2023 Q3 | 56.68 Million USD | -17.53% |
| 2023 Q2 | 68.73 Million USD | -13.26% |
| 2022 Q4 | 93.26 Million USD | -2.71% |
| 2022 FY | 93.26 Million USD | -21.77% |
| 2022 Q3 | 95.85 Million USD | 0.52% |
| 2022 Q2 | 95.35 Million USD | -12.25% |
| 2022 Q1 | 108.67 Million USD | -8.84% |
| 2021 Q3 | 127 Million USD | -4.88% |
| 2021 Q2 | 133.52 Million USD | -1.15% |
| 2021 FY | 119.21 Million USD | 19.04% |
| 2021 Q4 | 119.21 Million USD | -6.13% |
| 2021 Q1 | 135.08 Million USD | 34.89% |
| 2020 Q1 | 110.66 Million USD | -5.86% |
| 2020 Q4 | 100.14 Million USD | -1.34% |
| 2020 Q3 | 101.5 Million USD | -9.17% |
| 2020 Q2 | 111.75 Million USD | 0.98% |
| 2020 FY | 100.14 Million USD | -14.81% |
| 2019 Q1 | 116.49 Million USD | 4.71% |
| 2019 FY | 117.55 Million USD | 5.66% |
| 2019 Q2 | 110.63 Million USD | -5.03% |
| 2019 Q4 | 117.55 Million USD | 8.78% |
| 2019 Q3 | 108.07 Million USD | -2.32% |
| 2018 Q4 | 111.25 Million USD | 2.52% |
| 2018 FY | 111.25 Million USD | 87.65% |
| 2018 Q3 | 108.52 Million USD | 99.32% |
| 2018 Q2 | 54.44 Million USD | -3.73% |
| 2018 Q1 | 56.55 Million USD | -4.61% |
| 2017 FY | 59.28 Million USD | 50.36% |
| 2017 Q4 | 59.28 Million USD | 2.95% |
| 2017 Q3 | 57.58 Million USD | 2.29% |
| 2017 Q1 | 52.44 Million USD | 33.0% |
| 2017 Q2 | 56.29 Million USD | 7.35% |
| 2016 Q3 | 38.69 Million USD | -3.1% |
| 2016 FY | 39.42 Million USD | 5.27% |
| 2016 Q1 | 37.57 Million USD | 0.32% |
| 2016 Q2 | 39.93 Million USD | 6.27% |
| 2016 Q4 | 39.42 Million USD | 1.9% |
| 2015 FY | 37.45 Million USD | 31.39% |
| 2015 Q3 | 39.17 Million USD | 27.62% |
| 2015 Q4 | 37.45 Million USD | -4.39% |
| 2015 Q2 | 30.69 Million USD | 5.61% |
| 2015 Q1 | 29.06 Million CAD | 1.96% |
| 2014 FY | 28.5 Million USD | 21.82% |
| 2014 Q4 | 28.5 Million USD | -5.59% |
| 2014 Q2 | 34.3 Million USD | 80.12% |
| 2014 Q1 | 19.04 Million USD | -18.61% |
| 2014 Q3 | 30.19 Million USD | -11.98% |
| 2013 Q4 | 23.4 Million USD | -9.04% |
| 2013 FY | 23.4 Million USD | -36.02% |
| 2013 Q3 | 25.72 Million USD | -10.67% |
| 2013 Q2 | 28.8 Million USD | -11.65% |
| 2013 Q1 | 32.59 Million USD | -10.87% |
| 2012 Q3 | 41.4 Million USD | -0.47% |
| 2012 FY | 36.57 Million USD | -28.57% |
| 2012 Q2 | 41.6 Million USD | -9.58% |
| 2012 Q1 | 46 Million USD | -10.15% |
| 2012 Q4 | 36.57 Million USD | -11.67% |
| 2011 Q4 | 51.2 Million USD | -11.41% |
| 2011 FY | 51.2 Million USD | -27.14% |
| 2011 Q3 | 57.8 Million USD | -8.2% |
| 2011 Q2 | 62.96 Million USD | -5.23% |
| 2011 Q1 | 66.43 Million USD | -5.47% |
| 2010 Q4 | 70.27 Million USD | 46.82% |
| 2010 Q1 | 58.88 Million USD | -10.38% |
| 2010 FY | 70.27 Million USD | 6.98% |
| 2010 Q2 | 54.83 Million USD | -6.87% |
| 2010 Q3 | 47.86 Million USD | -12.71% |
| 2009 Q2 | 65.03 Million USD | 4.95% |
| 2009 Q3 | 68.1 Million USD | 4.72% |
| 2009 Q4 | 65.69 Million USD | -3.54% |
| 2009 FY | 65.69 Million USD | 50.69% |
| 2009 Q1 | 61.96 Million USD | 42.14% |
| 2008 Q1 | 94.42 Million USD | 26.66% |
| 2008 FY | 43.59 Million USD | -41.52% |
| 2008 Q4 | 43.59 Million USD | -36.03% |
| 2008 Q3 | 68.15 Million USD | -19.13% |
| 2008 Q2 | 84.27 Million USD | -10.75% |
| 2007 Q3 | 80.14 Million USD | -6.12% |
| 2007 Q4 | 74.55 Million USD | -6.98% |
| 2007 FY | 74.55 Million USD | 66.97% |
| 2007 Q1 | 84.56 Million USD | 89.39% |
| 2007 Q2 | 85.36 Million USD | 0.95% |
| 2006 Q2 | 57.12 Million USD | 32.23% |
| 2006 Q1 | 43.2 Million USD | -5.94% |
| 2006 FY | 44.65 Million USD | -2.79% |
| 2006 Q3 | 51.39 Million USD | -10.03% |
| 2006 Q4 | 44.65 Million USD | -13.13% |
| 2005 FY | 45.93 Million USD | -19.74% |
| 2005 Q2 | 50.86 Million USD | -19.41% |
| 2005 Q1 | 63.11 Million USD | 10.29% |
| 2005 Q3 | 49.03 Million USD | -3.58% |
| 2005 Q4 | 45.93 Million USD | -6.34% |
| 2004 Q4 | 57.22 Million USD | -2.24% |
| 2004 Q3 | 58.53 Million USD | -16.19% |
| 2004 Q2 | 69.84 Million USD | -9.99% |
| 2004 Q1 | 77.59 Million USD | 6.47% |
| 2004 FY | 57.22 Million USD | -21.47% |
| 2003 Q1 | 88.91 Million USD | -0.96% |
| 2003 FY | 72.87 Million USD | -18.83% |
| 2003 Q4 | 72.87 Million USD | -12.59% |
| 2003 Q3 | 83.36 Million USD | -6.39% |
| 2003 Q2 | 89.05 Million USD | 0.16% |
| 2002 Q1 | 102.56 Million CAD | 13.49% |
| 2002 Q4 | 89.78 Million USD | -5.51% |
| 2002 Q3 | 95.01 Million CAD | -4.21% |
| 2002 Q2 | 99.19 Million CAD | -3.29% |
| 2002 FY | 89.78 Million USD | -0.66% |
| 2001 Q3 | 93.27 Million CAD | 75.1% |
| 2001 Q1 | 52.97 Million CAD | -3.66% |
| 2001 FY | 90.37 Million USD | 64.34% |
| 2001 Q2 | 53.26 Million CAD | 0.55% |
| 2001 Q4 | 90.37 Million CAD | -3.1% |
| 2000 Q1 | 20.19 Million CAD | 9.72% |
| 2000 Q3 | 47.97 Million USD | 16.88% |
| 2000 FY | 54.99 Million USD | 198.81% |
| 2000 Q4 | 54.99 Million CAD | 14.63% |
| 2000 Q2 | 41.04 Million USD | 103.27% |
| 1999 Q1 | 11.73 Million USD | -5.64% |
| 1999 Q2 | 15.12 Million USD | 28.89% |
| 1999 FY | 18.4 Million USD | 48.0% |
| 1999 Q4 | 18.4 Million USD | -2.46% |
| 1999 Q3 | 18.86 Million USD | 24.76% |
| 1998 Q3 | 12.78 Million USD | -7.83% |
| 1998 Q2 | 13.86 Million USD | 84.46% |
| 1998 Q1 | 7.51 Million USD | -11.58% |
| 1998 Q4 | 12.43 Million USD | -2.71% |
| 1998 FY | 12.43 Million USD | 46.24% |
| 1997 Q1 | 11.39 Million USD | 0.0% |
| 1997 Q3 | 9.71 Million USD | -3.63% |
| 1997 Q4 | 8.5 Million USD | -12.51% |
| 1997 FY | 8.5 Million USD | -47.68% |
| 1997 Q2 | 10.08 Million USD | -11.52% |
| 1996 FY | 16.25 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aurora Cannabis Inc. | 838.67 Million CAD | 90.727% |
| Avicanna Inc. | 21.97 Million CAD | -253.96% |
| Avant Brands Inc. | 82.55 Million CAD | 5.794% |
| Cardiol Therapeutics Inc. | 36.7 Million CAD | -111.902% |
| Crescita Therapeutics Inc. | 24.59 Million CAD | -216.16% |
| Knight Therapeutics Inc. | 945.49 Million CAD | 91.775% |
| MediPharm Labs Corp. | 63.93 Million CAD | -21.634% |
| OrganiGram Holdings Inc. | 298.45 Million CAD | 73.943% |
| Canopy Growth Corporation | 1.3 Billion CAD | 94.019% |
| Willow Biosciences Inc. | 6.67 Million CAD | -1065.428% |
| Auxly Cannabis Group Inc. | 261.9 Million CAD | 70.306% |